Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sleep loss induces cholesterol-associated myelin dysfunction

  • Simayi, Reyila
  • Ficiarà, Eleonora
  • Faniyan, Oluwatomisin
  • Cerdán Cerdá, Antonio
  • Aboufares El Alaoui, Amina
  • Fiorini, Rosamaria
  • Cutignano, Adele
  • Piscitelli, Fabiana
  • Maroto, Aroa S.
  • Santos, Alexandra
  • Gallo, Federico del
  • Vivo, Luisa de
  • De Santis, Silvia
  • Bellesi, Michele
The increasing prevalence of sleep deprivation poses a public health challenge in modern society. Manifestations of reduced alertness, such as slowed reaction times and increased errors, are well-documented behavioral indicators of sleep loss (SL). Yet, the biological consequences of sleep deprivation and their role in behavioral impairment remain elusive. Our study reveals significant effects of sleep deprivation on myelin integrity. As a result, we identify increased conduction delays in nerve signal propagation, hindered interhemispheric synchronization, and impaired cognitive and motor performance associated with SL. By profiling oligodendrocyte transcriptome and lipidome, we observe SL-induced endoplasmic reticulum stress and lipid metabolism dysregulation, particularly affecting cholesterol homeostasis. Boosting cholesterol transport to myelin sheaths prevents SL effects on nerve signal propagation and behavior. Our findings highlight a possible role of oligodendrocyte cholesterol dysregulation in behavioral deficits associated with SL and unveil a novel target for intervention., We thank Ms. Ester Biecher for her help with the corticosterone assessment. This work was supported by Wellcome Trust (215267/Z/19/Z to M.B., 217546/Z/19/Z to L.d.V.), Cariverona Foundation (PhD scholarship for A.A.E.A.), Armenise-Harvard Foundation (CDA to L.d.V.), the European Union–Next generation EU, Ministry of University and Research-Promotion and Development Fund- Ministerial Decree N737/2021 -MYSLEEP (L.d.V.), PRIN 2022 (2022YSTP5L, L.d.V.), the Spanish Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación (PID2021-128909NA-I00 and CNS2023-144883, S.D.S.), the Programs for Centres of Excellence in R&D Severo Ochoa (CEX2021-001165-S, S.D.S.), and by the Generalitat Valenciana through a Subvencion para la contratación de investigadoras e investigadores doctores de excelencia 2021 (CIDEGENT/2021/015, S.D.S.)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multiscale Approximations to Understand the Complex Role of Microglia in Alzheimer's Disease

  • Martínez-Tazo, Patricia
  • Mejías-Ortega, Marina
  • López-López, Verónica
  • Bhojwani-Cabrera, Aysha M.
  • Saxton, Emma
  • Canals, Santiago
  • Hardingham, Giles E.
  • Gutiérrez, Antonia
  • López-Atalaya, José P.
  • De Santis, Silvia
Microglia, the resident innate immune cells of the central nervous system, play a pivotal role in the pathogenesis of Alzheimer's disease (AD). Microglia are now recognized as a highly dynamic and heterogeneous population whose molecular and functional states vary with spatial context, disease stage, and genetic background. Recent discoveries across multiple scales from genetics, molecular and cellular biology, to systems-level imaging and epidemiology have underscored the complex and context-dependent contributions of microglia to the AD cascade. Together, these findings highlight the need for integrative, multiscale approaches that bridge molecular, cellular, and systemic perspectives to elucidate the diverse roles of microglia and their impact on disease progression. This mini-review discusses recent advances in understanding microglial biology across these dimensions and outlines current challenges toward achieving a more unified and therapeutically oriented framework for studying microglia in AD., This work was supported by the Instituto de Salud Carlos III (PI24/00274), the Generalitat Valenciana (PROMETEO 2020/007, CIESGT/2025/06, CIPROM/2022/15, CIDEGENT/2021/015), the Ministerio de Ciencia e Innovación (PID2021-129053OB-I00, PID2021-128909NA-I00, CNS2023-144883, RTI2018-102260-B-I00, PID2021-128158NB-C21, PID2024-162400OB-C21, PCI2024-153491), the Fundacion Pasqual Maragall (2023–1296), the UK Dementia Research Institute, the Program for Centres of Excellence in R&D Severo Ochoa (CEX2021-001165-S) the Junta de Andalucía (CTS950-G-FEDER), and PMT is supported by the Spanish Ministry through a PhD fellowship FPU20/05737., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed